A PHASE 2A, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ORAL PF-06651600 AND PF 06700841 AS INDUCTION AND OPEN LABEL EXTENSION TREATMENT IN SUBJECTS WITH MODERATE TO SEVERE CROHN’S DISEASE
2022-06-27
عنوان الدراسة
A PHASE 2A, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ORAL PF-06651600 AND PF 06700841 AS INDUCTION AND OPEN LABEL EXTENSION TREATMENT IN SUBJECTS WITH MODERATE TO SEVERE CROHN’S DISEASE
داعم الدراسة
Pfizer
دواء الدراسة
PF-06651600
رقم بروتوكول الدراسة
B7981007
حالة الدراسة
Completed
موقع الدراسة
NGHA-R,KKUH, King Abdulaziz Medical City NG (Jeddah)
مرحلة الدراسة
2a
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。